Related Experiment Video
Updated: Feb 13, 2026

Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease
Published on: May 13, 2010
Aptamers Selected for Recognizing Amyloid β-Protein-A Case for Cautious Optimism
1Division of Biomedical Science and Biochemistry, Research School of Biology, The Australian National University, Canberra, ACT 2601, Australia. farid.rahimi@anu.edu.au.
Aptamers, or oligonucleotide ligands, face challenges in recognizing amyloid beta-protein (Aβ) due to Aβ's complex nature. Studies highlight the need for pure targets and specific aptamer characterization for successful Aβ recognition.
Area of Science:
- Biochemistry
- Molecular Biology
- Neuroscience
Background:
- Aptamers are oligonucleotide ligands with broad molecular recognition capabilities.
- Amyloid β-protein (Aβ) is intrinsically disordered, existing in dynamic, metastable states.
- Aβ's role in Alzheimer disease pathogenesis is significant but debated.
Purpose of the Study:
- To review aptamer applications for amyloid β-protein (Aβ) recognition.
- To identify challenges and limitations in Aβ-aptamer studies.
- To emphasize requirements for successful aptamer selection against Aβ.
Main Methods:
- Literature review of aptamer selection studies targeting Aβ assemblies.
- Analysis of reported interactions between aptamers and Aβ.
- Evaluation of factors affecting aptamer specificity and efficacy.
Main Results:
- Aptamer application to Aβ has been limited by Aβ's metastable nature and dynamic conformational ensembles.
- Nonspecific interactions between aptamers and Aβ assemblies are frequently reported.
- The inherent affinity of RNA oligonucleotides for β-sheet structures complicates Aβ recognition.
Conclusions:
- Purity and uniformity of the Aβ target are crucial for reliable aptamer selection.
- Rigorous characterization of aptamer specificity is essential for Aβ-targeting aptamers.
- Overcoming challenges requires careful consideration of Aβ's properties and aptamer-target interactions.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Protein and Protein Structure
A protein's shape is critical to its function. For example, an enzyme...
Multi-pass Transmembrane Proteins and β-barrels
α-Helix containing multi-pass transmembrane proteins
Multi-pass transmembrane proteins such as...
Protein Families
What is Natural Selection?

